Ambroxol hydrochloride - Agyany Pharma
Latest Information Update: 07 Feb 2024
At a glance
- Originator Agyany Pharmaceuticals
- Class Aniline compounds; Antibronchitics; Cyclohexylamines; Expectorants; Small molecules
- Mechanism of Action Glucosylceramidase modulators; Protein folding stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Parkinson's disease
Most Recent Events
- 24 Oct 2023 Phase-I/II clinical trials in Parkinson's disease (Newly diagnosed) in Israel (PO) (NCT06193421)